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ABSTRACT 
Autism is most common mental disabilities in childhood with unknown aetiology nowadays. 
In our Siddha paediatric text, the symptoms of Mantha sanni are nearly correlated with 
Autism Spectrum Disorder (ASD). Objectives: The Main objectives of the study is to evaluate 
the Siddha therapeutic management and to analyse the clinical assessment of Mantha sanni 
(Autism Spectrum Disorder) with Experimental formulations and procedures and the 
secondary objectives are to calibrate the resemblance and the equivalence of Mantha Sanni 
with Autism Spectrum Disorder and to explore the Siddha therapeutic management in 
Autism children. Methods: In preclinical studies of Physicochemical, Phytochemical 
activities and Pharmacological activities were done. In clinical studies, among 30 children 
were included in inclusion criteria and received Kuruver kudineer as internal twice a day and 
Sambrani thuvalai and Mysatchi pugai as external once in a day. The Experimental period 
was 90 days and the activities of ASD children were recorded 0th day followed by every 30th 
day. Results and Discussion: In this clinical study indicating that both internal and external 
medicine had superior action as far as improvement in ASD is considered. Since Kuruver 
Kudineer use is to enhance cognitive skills, enhance nerve impulse transmission, research 
has been focused on the mechanism behind this activity. Thuvalai with Sambrani ennai use to 
enhance the Sitting tolerance, invigorating feeling and can give comfort. Fumigation with 
Mysatchi pugai is one of the methods of treatment in ancient period. It has to enhancing the 
mind calming activity, reduced hyperactivity, induced sound sleep, reduced screaming and 
irritable cry. In Statistical analysis, there is significant difference between before and after 
treatment on clinical assessment parameter score i.e. 86% improvement in this score after 
treatment. Based on the results of this clinical study, it can be conclude that Kuruver kudineer 
as internal and Sambrani thuvalai and Mysatchi pugai as external. It has a definite action as 
well as clinical efficacy on symptoms in ASD children seen in regular OPD and IPD. The 
effects of Internal and external therapies may be due individual drugs multipronged action. 
Further study is required for scientific validation to prove its clinical efficacy in multicentre 
clinical study. 
KEYWORDS: Mantha Sanni, Autism Spectrum disorder, Kuruver Kudineer, Sambrani thuvalai 
and Mysatchi pugai. 
INTRODUCTION 
Autism in this era is the most common 
developmental disorder seen in paediatric 
population. It is associated with Impairment in Social 
and communication Skills, Emotional skills, 
Behavioural problems sensory issues and lack of 
cognitive development. The Word Autism comes 
from the Greek word “Autos” which means self. It 
describes condition in which a person removed from 
social interaction. In other words, he becomes an 
“isolated self”. Eugen Bleuler, a swiss psychiatrist was 
the first person to use this term[1].  
 The latest analysis from the centres for 
Disease control and prevention estimate that 1 in 68 
has ASD. The Early signs of ASD can be seen by above 
18 months after birth. In all over the world, it is 
believed that 1 in 42 boys and 1 in 189 girls are 
suffering from it. This surveillance study identified 1 
in 68 children. That represents a tenfold rise in the 
past 40 years. It was found about 1 to 1.5 % autistic 
children between ages 2-9 years says Dr.N.K.Arora, 
Executive director of the international clinical 
epidemiology network trust which led the study. That 
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means the prevalence rate is 23 children of every 
10,000 in India. In Tamil Nadu, the prevalence rate is 
1:116 and in Chennai, that is 1:100.[2]  
 In India, Siddha is one of the oldest systems of 
medicine practiced. The word 'Siddha' comes from 
'Siddhi' which means an object to be attained or 
perfection of heavenly bliss. The basis of treatment is 
the three element theory or 'Trithodam' (three 
humours). The three humours are Vatha (air), Pitta 
(bile) and Kapha (phlegm). It is believed that without 
these humours an individual cannot exist and 
imbalance of these may cause diseases. The main aim 
of Siddha is to assure a healthy life to mankind. In our 
Siddha paediatric text, the symptoms of Mantha sanni 
are nearly correlated with Autism Spectrum Disorder 
(ASD) [3]. Thus the aim and objectives of the present 
study were to test the efficacy of the Siddha 
medicines/methodologies in ASD children. 
 In order to the drugs chosen for the project 
included Kuruver Kudineer as internal medicine, 
Sambrani Thuvalai for Thuvalai and Mysatchi Pugai 
for fumigation therapy as external, all of which have 
been used in the Siddha system of medicine for many 
centuries. All the ingredients in both Internal and 
External medicines are herbal. This Study is 
conducted on ASD to see the improvement in the 
quality of life by employing the Siddha therapeutic 
formulations and procedures. 
Materials and Methods 
Preparation of experimental formulations 
 Kuruver kudineer as internal and Sambrani 
thuvalai, Mysatchi pugai as external were identified 
for this study. Raw drugs to prepare the products 
were purchased from the well reputed country shop 
in Tambaram. The raw materials have got 
authentication from the department of Medicinal 
Botany, National institute of Siddha, Chennai. After 
process the medicine was proper purification and 
prepared in Gunapadam lab of NIS. The Prepared 
medicine was stored in glass container authenticated 
by the concerned guide for its completeness.  
Kuruver Kudineer 
  Kuruver kudineer[4] was prepared as 
described as in the Sasthric Siddha literature in Bala 
vagadam such as Vettiver (Vettiver zaizanoids), 
Vilamichu (Plectranthus vettiveroids), Parpadagam 
(Hedyotis corymbosa), Siruthaeku (Clerodendrum 
serratum) roots are used in above plants and Chukku 
(Zingiber officinalae) has dried rhizome. All the drugs 
are taken in ¼ palam as equal quantity. 
Preparation method 
Ingredients mentioned above are made as a 
coarse powder and then soaked it in a vessel 
containing of water 1 Padi (1 lit.) and heat till it 
comes to 1/8th of its volume. Twice a day. 
Duration: 90 days 
Dispensing: Prepared medicine will be given as 
decoction. 
External medicine I-Sambrani thuvalai 
Sambrani thuvalai[5] was prepared as 
described as in the Siddha literature of Dhanvanthri 
thylam such as all parts of Vellerukan samoolam 
(Calotropis giganteae) and gum resins of Sambrani 
(Styrax benzoin) in 1kg. The oil of Neem (Azadiracta 
indica) in 2 litres. 
Method: Take all the above ingredients in equal 
quantity except neem oil and make it as a decoction 
then boiled with neem oil. After the oil is apply over 
whole body like a thuvalai once in a day[6]. 
Duration: 90 days 
External Medicine- II Mysatchi pugai 
Mysatchi Pugai[3] was prepared as described as in the 
sasthric Siddha literature in Bala vagadam such as 
Gums of Mysatchi (Shorea robusta), gum resins of 
Sambrani (Styrax benzoin), Woods of Agirkattai 
(Aquillaris agalocha), Seeds of Sanninayagam (Nigella 
sativum) and roots of Velai ver (Cleome viscosa) and 
Sathisaranai ver (Trianthema decandra). All the 
above plants are taken in ½ Kg. 
 Method 
Take1- 4 ingredients mentioned above in equal 
quantity make as a powder and then 5-6 ingredients 
make it as a flamed substances. After that fumigate 
once in a day[7]. 
Duration: 90 days  
Preclinical studies 
Physicochemical and Phytochemical Studies 
 The physicochemical and phytochemical 
studies were done in The Tamil nadu, Dr. MGR 
University, Guindy, Chennai. The physicochemical 
testing employed for Kuruver kudineer profiling 
which is depend on the specific characteristics of 
formulation as per method given in PLIM guidelines 
and Siddha Pharmacopoeia of India contains various 
parameters for testing such as 1. Loss on drying, 
2.Total ash value, 3.Acid insoluble ash, 4.Water 
soluble ash, 5.Water soluble extraction, 6.Alcohol 
soluble extraction. The Phytochemical studies were 
employed for Kuruver Kudineer profiling contains 
various parameters such as 1. Alkaloids 
2.Carbohydrates 3.Glycoside 4.Saponin 5.Phytosterol 
6.Phenols 7.Tannins 8.Flavonoids 9.Proteins and 
amino acids 10.Diterpene 11.Gum & Mucilage 12.Fat 
& Fixed Oil 13.Quinones. 
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Biochemical analysis 
 The Chemical analysis of Kuruver Kudineer 
was done at the Biochemistry lab at National Institute 
of Siddha, Chennai by the method of Kolkate. The 
Biochemical studies were employed for Kuruver 
Kudineer profiling contains various parameters such 
as Acid radicals test, Basic radical test and 
Miscellaneous test. 
Pharmacological Activity (Anxiolytic study-
Elevated plus maze method) 
 The pharmacological study protocol has got 
an approval from Institutional ethical committee of 
National Institute of Siddha, Chennai (NIS/IAEC/-
IV/04105012017). 
The Swiss albino Mice age and weight are 6 – 
8 weeks/20-35g and the gender was Male and female 
were selected this study. The drug was administrated 
by oral route. The room temperature and humidity 
was 22+40-65%. Same sex of 3 animals was housed 
in propylene cages with husk bedding. Each animal 
has marked in picric acid on the fur for identification 
(Head, Neck, Body and Base of tail) and it was 
indicated in cage card along with the number. 
CPCSEA guidelines would be strictly adhered. 
Animals would be monitored for health, food with 
adequate nutrition (Rodent pellets) and water 
atlibidum etc. for 24 x7 days per week. Animal 
husbandry would be 12-hour light and12-hour dark 
cycle. Monitoring room temperature at 22°C (±3°) 
and relative humidity are 30–70%. Polypropylene 
cages would be used with proper husk bedding. 
Animal excreta would be disposed properly 
and monitored hygienic condition. All animals would 
be observed for signs of illness, injury or abnormal 
behaviour treated with veterinary surgeon. If any 
animal die immediately post-mortem would done for 
observation of autopsy changes. Diseased animals 
would be monitored, treated and quarantined in the 
separate cages. 
After the experimental period, animals would 
be reutilized for another study followed by 
acclimation period or else would be leave 
independently. 
Clinical Studies 
  The Present study was a interventional, 
preclinical and open clinical, out-patient and In-
patient based, Single Arm trail conducted in the 
department of Kuzhandai Maruthvam (Paediatric), 
National Institute of Siddha, Chennai. It was 
conducted during 2015 to Oct 2018 after obtains 
approval from Institutional Ethics Committee NIS/ 
IEC/2016/11-19/ 14.10.2016. After getting the 
approval from committee, registration done in CTRI 
and number is CTRI/2017/05/008698. The first 60 
children with ASD were screened during this period. 
Children of either sex between the age group of 3-12 
years who were diagnosed with ASD were identified 
and included in the study. Other type of ASD along 
with epilepsy, cerebral palsy and heart disease were 
excluded from the study. 30 children satisfied the 
inclusion criteria and were willing to participate in 
the study, signed the informed consent. The parents 
of children who were enrolled was informed about 
the study, trail drug, possible outcomes and the 
objectives of the study in the language and terms 
understandable for them. 
 All the 30 children, under OPD and ipd 
treatment received Kuruver kudineer as Internal (3-6 
years – 30ml, 7-9 years – 40 ml, 10-12 years – 50ml) 
twice a day and Sambrani thuvalai, Mysatchi pugai as 
external once in a day. Experimental period was 90 
days and the improvement was recorded 0th day and 
followed by every 90th day. Experimental 
formulations were assigned to each subject and 
regular study drug reconciliation was performed to 
document the drug assigned, consumed and 
remaining are logged on the drug reconciliation form 
with sign and date. 
Clinical assessment parameters 
1.Social relationship and reciprocity such as Eye 
contact, Social smile, Solitary and repetitive activities, 
Social interaction and Peer relationship.  
2. Emotional responsiveness such as Inappropriate 
emotional response, Exaggerated emotions, Self-
stimulating emotions, Fear for danger, Excited for no 
apparent reasons.  
3.Speech: language and communication such as 
Non-verbal language to communicate the others, 
Stereotyped and repetitive use of language, Unusual 
noises, Meaningless words, Understand the meaning 
of communication.  
4. Behavioural patterns such as Hyperactivity and 
restlessness, Aggressive behaviour Attachment to 
inanimate objects, Self-injurious behaviour, Temper 
tantrums. 
5. Sensory aspects such as unusual visions, Stares 
into space for long periods of time, Insensitive to 
pain, Responds to object, Tracking objects.  
 Children were assessed for improvement on 
0th, 30th, 60th, 90th day of treatment and the results 
were entered in the assessment forms. The results 
were analysed by computing the scores as 0 score – 
Never (5), 1 score – Sometimes (10), 2 score – Often 
(15), 3 score – Mostly (20), 4 score – Always (25) 
exhibits the skills in Autism Clinical Assessment 
Parameters. 
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Autistic child Severe  Moderate to severe Mild to Moderate  Mild  Normal to Mild  
Score Range (125-249) (250-374) (375-499) (500-624) ( >625) 
DATA COLLECTION FORMS 
FORM 1 Screening and Selection Proforma 
FORM 2 Consent Form 
FORM 3 Case Report Profoma 
FORM 4 Patient’s Information Sheet  
FORM 5 Drug Compliance 
FORM 6 Withdrawal Form  
FORM 7adverse Reaction Form 
FORM 8 Pharmacovigilence Form 
FORM 9 Dietary Advice Form 
RESULTS AND DISCUSSION 
Physicochemical Analysis of Kuruver Kudineer 
 The physicochemical testing employed for Kuruver kudineer profiling which is depend on the specific 
characteristics of formulation as per method given in PLIM guidelines and Siddha Pharmacopoeia of India 
contains various parameters for testing such as 1. Loss on drying – 5.54%, 2.Total ash value- 6.82%, 3.Acid 
insoluble ash-1.81%, 4.Water soluble ash- 2.40%, 5.Water soluble extraction – 33.23%, 6.Alcohol soluble 
extraction – 10.76%. 
Phytocomponents Result 
  The Phytochemical studies were employed for Kuruver Kudineer profiling contains various parameters 
indicates positive results such as 1. Alkaloids in Mayer’s test, 2.Carbohydrates in Molish’s and Benidicts test 
3.Saponin in Froth’s test, 4.Flavonoids in Alkaline Reagent and Lead acetate Test, 5.Proteins and amino acids, 
6.Diterpene in Copper Acetate Test, 7.Gum & Mucilage, 8.Fat & Fixed Oil, 9.Quinones in NAOH + Extract. 
Biochemical analysis of Kuruver kudineer 
Results of Acid radicals studies 
Interpretation 
The acidic radicals test shows the presence of Sulphate, Chloride. 
Results of basic radicals studies 
Interpretation 
The basic radical test shows the presence of Iron, and absence of heavy metals such as lead, arsenic and 
mercury. 
Results of Miscellaneous test  
Interpretation  
The Miscellaneous test shows the presence of Alkaloid, Tannic acid, Type of Compounds.  
Table 1: Anxiolytic activity of Kuruver Kudineer
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average Calculation (n=6) 
Control group 
Open arm Closed arm 
Number of entry 5 Number of entry 12 
Spent time 34sec Spent time 1min56sec 
Standard group 
(Alprazolam IP) 
Open arm Closed arm 
Number of entry 8 Number of entry 11 
Spent time 1min7sec Spent time 2min4sec 
Low Dose 
(Kuruver 
kudineer) 
Open arm Closed arm 
Number of entry 13 Number of entry 12 
Spent time 1min8sec Spent time 2min5sec 
High Dose 
(Kuruver 
kudineer) 
Open arm Closed arm 
Number of entry 9 Number of entry 10 
Spent time 1min2sec Spent time 2min9sec 
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It shows low dose and high dose of Kuruver kudineer action were good when compared to control and standard 
group (I.p. Alprazolam). The results were satisfactorily good.  
Clinical studies 
 In this study we tested the influence of adding Thuvalai and fumigation to Kuruver kudineer on the level 
of improvement in ASD children. Based on the results of study, both internal and external medicine had 
superior action as far as improvement in ASD children has concerned. Since Kuruver Kudineer use is to enhance 
cognitive skills, enhance nerve impulse transmission, research has been focused on the mechanism behind this 
activity. Thuvalai with Sambrani ennai use to enhance the Sitting tolerance, invigorating feeling and can give 
comfort. Fumigation with Mysatchi pugai is one of the methods of treatment in ancient period. It has to 
enhancing the mind calming activity, reduced hyperactivity, induced sound sleep, reduced screaming and 
irritable cry.  
Table 2: Summary values of Clinical assessment parameters for Autism spectrum disorder in Children 
Treatment No. of Patients Mean Std Dev Min Max 
0 score (Before) 30 248.33 102.53 125 600 
0 Score (After) 30 503.33 125.55 250 625 
4 Score (Before) 30 49.66 20.50 25 120 
4 Score (After) 30 100.66 25.11 50 125 
Social skills (Before) 30 49.83 21.06 25 120 
Social Skills (After) 30 102.83 25.85 50 150 
Emotional skills (Before) 30 47.16 22.19 25 120 
Emotional skills (After) 30 98.66 26.12 50 125 
Communication Skills (Before) 30 50.66 20.16 25 120 
Communication Skills (After) 30 98 25.37 50 125 
Behaviour Skills (Before) 30 52.66 22.88 25 120 
Behaviour Skills (After) 30 104.5 27.92 50 125 
Sensory Skills (Before) 30 46.83 19.54 25 120 
Sensory skills (After) 30 99.66 25.01 50 125 
Table 3: Statistical significance of treatment on ASD 
Treatment t value P value 
0 score (Before & After) 11.46 >1.0000 
4 Score (Before & After) 11.46 >1.0000 
Social skills (Before & After) 10.53 >1.0000 
Emotional skills (Before & After) 11.00 >1.0000 
Communication Skills (Before & After ) 10.36 >1.0000 
Behaviour Skills (Before & After) 10.75 >1.0000 
Sensory Skills (Before & After) 11.73 >1.0000 
 The mean and standard deviation of clinical 
assessment parameters, before and after treatment of 
0 score, 4 Score, Social skills, Emotional skills, 
Communication Skills, Behaviour Skills, Sensory 
Skills were 283.33±102.53, 503.33±125.55, 49.66 
±20.50, 100.66±25.11, 49.83±21.06, 102.83±25.85, 
47.16±22.19, 98.66±26.12, 50.66±20.16, 98±25.37, 
52.66±22.88, 104.5±27.92, 46.83±19.54, 99.66±25.01 
respectively which is statistically highly significant 
(Score 0:t- value - 11.46, P>1.0000, Score 4: t- value – 
11.46, P>1.0000, Social skills: t- value – 10.53, 
P>1.0000, Emotional skills: t- value – 11.00, 
P>1.0000, Communication skills: t- value – 10.36, 
P>1.0000, Behavioural Skills: t- value – 10.75, 
P>1.0000, Sensory skills: t- value – 11.73, P>1.0000). 
 There is significant difference between before 
and after treatment on clinical assessment parameter 
score i.e., 86% improvement in this score after 
treatment. 
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CONCLUSION 
  In general, based on the results of this study, 
were found to be improvement in all the cases. No 
adverse effects were noticed during the treatment. 
Further follow up of these patients showed good 
recovery and fine improvement. The preparation of 
the medicine is simple as well as economical. The 
trial drug has anxiolytic actions. The Global burden of 
Mantha sanni (Autism spectrum disorder), increasing 
prevalence and its impact in reducing the quality of 
life in children has prompted the author to choose an 
efficient and nutritive drug which is believed to good 
in central nervous system. The treatment of Mantha 
sanni with Kuruver Kudineer has showed good 
response with no adverse effect, very effective and 
simple to administer. This has, in turn, provided a 
golden opportunity for new drug established in the 
management of Mantha sanni It can be conclude that 
Kuruver kudineer as internal and Sambrani thuvalai 
and Mysatchi pugai as external and it has a definite 
action as well as clinical efficacy on symptoms in ASD 
children seen in regular OPD and IPD. The effects of 
Internal and external therapies may be due 
individual drugs multipronged action. Further study 
is required for scientific validation to prove its 
clinical efficacy in multicentre clinical study. 
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